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Identity 
Other names: AIB1 (amplified in breast cancer-1); 
ACTR; RAC3 (RAR-associated coactivator 3); SRC3 
(steroid receptor coactivator protein 3); TRAM-1 
(thyroid hormone receptor activator molecule 1); pCIP 
(p300/CBP-integrator associated protein; mouse) 




The human AIB1 gene spans approximately155 kb and 
has 23 exons.  
RNA Expression: Highly expressed in placenta, heart, 
pancreas, muscle, brain, liver, uterus, pituitary, 
mammary gland, and testis. Lower levels of expression 
are found in lung and kidney. 
Transcription 
Transcription is from centromere to telomere. There are 
two reported transcripts: Isoform a (7935 bp) and 
isoform b (7923 bp). Isoform b uses an alternate in-







Genomic structure of NCOA3 with NCBI Build 35.1 genomic positions indicated. Black boxes indicate exons. The translational start (*) 
and stop codons (^) are also shown. UTR, untranslated region. 
 
 










Chromosome 8 (AF010227). 
Protein 
Description 
A member of the p160/steroid receptor coactivator 
family. 1424 amino acids. 155 kDa (130 kDa encoded 
by isoform b). 
Expression 
Protein expression found in testis, lung, liver, brain, 
mammary gland, and heart. 
Localisation 
Mainly cytoplasmic and weakly nuclear. The protein 
translocates to the nucleus upon TNF activation and 
phosphorylation. 
Function 
A transcriptional coactivator that interacts with nuclear 
hormone receptors to enhance their transcriptional 
activation. AIB1 interacts with other transcription 
factors including TP52, NfkB, and ER81. It has 
intrinsic histone acytyltransferase activity and recruits 
CREB Binding Protein (CBP)/p300 cointegrators to a 






The gene copy number and expression levels are 
altered in several cancer types. Overexpression has 
been found in breast, ovarian, endometrial, gastric, and 
pancreatic cancers. Amplification of AIB1 in 
hepatocellular carcinoma is associated with poor 
prognosis. Increased numbers of polyglutamine repeats 
correlate with higher breast cancer risk in BRCA1 and 
BRCA2 mutation carriers. However, the polymorphic 
repeat genotype does not influence postmenopausal 
breast cancer risk among Caucasian women in the 
general population. 
To be noted 
Note 
Overexpression of AIB1 in tamoxifen-treated patients 
is associated with tamoxifen resistance and worse 
survival. Tamoxifen behaves as estrogen in breast 
cancer cells that express high levels of AIB1 and 
HER2, resulting in de novo resistance. 
An N-terminally deleted isoform (AIB1-Delta3) which 
lacks exon 3 was identified and found to be 
overexpressed in breast cancer cell lines and in tumors 
from breast cancer patients. Of interest, this splice 
variant has more potent transcriptional coactivation 
properties on estrogen and progesterone receptors than 
the full-length AIB1 protein. 
 
Structural features of AIB1. AIB1 contains a basic helix-loop-helix preceding a PAS (Per/Arnt/Sim) region, serine-and threonine-rich 
regions, and a charged cluster.  There is also a glutamine-rich region that contains a polyglutamine tract. The central portion of the 
protein contains three LXXLL motifs (L=leucine, X=any amino acid) that are critical for interaction with ligand-bound nuclear receptors. An 
activation domain located C-terminal to the nuclear receptor interaction domain contains three LXXLL motifs that are important for 
interaction with general transcription cointegrators, CREB binding protein (CBP)/p300. A second transcriptional activation domain is 
responsible for interaction with histone methyltransferases, coactivator-associated arginine methyltranserase 1 (CARM1) and PRMT1. 
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